Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
- Moneycontrol
- Lupin Launches Generic Combivir Tablets - RTT News
- Moneycontrol
- Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times
- Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement
- LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
- LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS
- New Advances in Chronic Hepatitis B - Medscape
- New Advances in Chronic Hepatitis BMedscapeTenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
